Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression

• Eran Cohen,

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯
• Dana Avrahami,

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯
• Kati Frid,

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯
• Tamar Canello,

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯
• Ephrat Levy Lahad,

  Affiliations Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel, Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Sharon Zeligson,

  Affiliations Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel, Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Shira Perlberg,

  Affiliations Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel, Hebrew University-Hadassah Medical School, Jerusalem, Israel

  ⨯
• Joab Chapman,

  Affiliation Department of Neurology, Sheba Medical Center, Sackler Faculty, Tel Aviv University, Israel

  ⨯
• Oren S. Cohen,

  Affiliation Department of Neurology, Sheba Medical Center, Sackler Faculty, Tel Aviv University, Israel

  ⨯
• Esther Kahana,

  Affiliation Department of Neurology, Barzilai Medical Center, Ashkelon, Israel

  ⨯
• Iris Lavon,

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯
• Ruth Gabizon

  * E-mail: gabizonr@hadassah.org.il

  Affiliation Department of Neurology, Hadassah Medical Center, The Agnes Ginges Center of Human Neurogenetics, Jerusalem, Israel

  ⨯